Collegium Pharmaceutical Inc (COLL)

[floblu14]

FWIW -

Why Collegium Pharmaceutical (COLL) Could Beat Earnings Estimates Again

Zacks Equity Research
Wed, January 24, 2024 at 12:10 PM EST

COLL
+0.55%

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Collegium Pharmaceutical (COLL), which belongs to the Zacks Medical - Drugs industry.

This specialty pharmaceutical company has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 5.67%.

For the last reported quarter, Collegium Pharmaceutical came out with earnings of $1.34 per share versus the Zacks Consensus Estimate of $1.24 per share, representing a surprise of 8.06%. For the previous quarter, the company was expected to post earnings of $1.22 per share and it actually produced earnings of $1.26 per share, delivering a surprise of 3.28%.

Thanks in part to this history, there has been a favorable change in earnings estimates for Collegium Pharmaceutical lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank.

https://finance.yahoo.com/news/why-collegium-pharmaceutical-coll-could-171009011.html